The study has been carried out in 44 specialized tertiary Italian centers for physical medicine and rehabilitation, orthopedics, neurology, neurosurgery, and rheumatology
According to the FDA, Wegovy is indicated for chronic weight management in patients with a body mass index (BMI) of 27 kg/m2 or greater who have at least one weight-related ailment or in patients with a BMI of 30 kg/m2 or greater
Nearly 45.7 million adults (16%) aged 26 years or older
Since losing 30 pounds on semaglutide, she reports an improved relationship with food, a more varied diet (no longer gluten-free/dairy-free), and decreased exercise bulimia. Stories like these give me hope that we will someday have a new host of FDA-approved medications to improve outcomes in patients with disordered eating patterns
Fardouly J, Vartanian LR (2016) Social media and body image concerns: current research and future directions